| abstract |
The present invention provides a compound and pharmaceutical composition related to psychoneurological diseases or malignant tumors, the use thereof, or a method for preventing, improving, inhibiting deterioration and/or treating psychoneurological diseases or malignant tumors using the same. In one or more embodiments, a compound represented by the following general formula (I) or (II) or a pharmaceutically acceptable salt thereof is disclosed. [Regarding formula (I), R 1 and R 2 are independently hydrogen atoms or C 1-6 hydrocarbon chains, R 3 is (R 3 ), Z and the atoms marked with a and b form a benzene ring, etc. , R 4 is a hydrogen atom, etc. Regarding formula (II), X and Y are independently S or NH, R 5 is (R 5 ), Z and the atoms marked with a and b together form a benzene ring, etc., R 6 is a hydrogen atom, etc.]. |